EP 0000791 A3 19790307 - MEDICAMENT-SUBSTITUTED HAPTEN CONJUGATES, PROCESS FOR THEIR PREPARATION, THEIR USE AS PHARMACEUTICALS AND HAPTEN USED IN THEIR PREPARATION
Title (en)
MEDICAMENT-SUBSTITUTED HAPTEN CONJUGATES, PROCESS FOR THEIR PREPARATION, THEIR USE AS PHARMACEUTICALS AND HAPTEN USED IN THEIR PREPARATION
Publication
Application
Priority
GB 3427977 A 19770816
Abstract (en)
[origin: EP0000791A2] The present invention provides conjugates between levan or dextran and a medicament, processes for preparing them, pharmaceutical compositions containing them and intermediates in their preparation. The conjugates create tolerance to the administration of the medicaments in mammals.
IPC 1-7
IPC 8 full level
A61K 39/00 (2006.01); A61K 39/35 (2006.01); A61K 39/385 (2006.01); C08B 37/00 (2006.01)
CPC (source: EP US)
A61K 39/35 (2013.01 - EP US); A61K 39/385 (2013.01 - EP US); C08B 37/0051 (2013.01 - EP US); A61K 2039/6012 (2013.01 - EP US)
Citation (search report)
- CHEMICAL ABSTRACTS, vol. 67, 106927f (1967) & Immunochemistry, 4(5), 331-343 (1967)
- CHEMICAL ABSTRACTS, vol. 75, 149980a (1971) & Eur. I. Immunol., 1(2), 98-106 (1971)
- CHEMICAL ABSTRACTS, vol. 85, 92018t (1976) & Role Immunol. Factors Infect., Allerg., Autoimmune Processes", edited by R.F. Beers Jr. et al, New York, 1976, pages 185-98
Designated contracting state (EPC)
CH DE GB
DOCDB simple family (publication)
EP 0000791 A2 19790221; EP 0000791 A3 19790307; EP 0000791 B1 19811230; CA 1114812 A 19811222; DE 2861470 D1 19820218; JP S5446841 A 19790413; US 4260602 A 19810407
DOCDB simple family (application)
EP 78100669 A 19780816; CA 309347 A 19780815; DE 2861470 T 19780816; JP 9943378 A 19780815; US 93387778 A 19780815